©The Author(s) 2025.
World J Stem Cells. Dec 26, 2025; 17(12): 106128
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.106128
Published online Dec 26, 2025. doi: 10.4252/wjsc.v17.i12.106128
Table 1 Experimental grouping
| Group | Treatment |
| Control | BMSCs + PBS |
| L-nHAPs (low concentration) | BMSCs + 2 MCF nHAPs |
| M-nHAPs (medium concentration) | BMSCs + 4 MCF nHAPs |
| H-nHAPs (high concentration) | BMSCs + 6 MCF nHAPs |
| L-CNPs (low concentration) | BMSCs + 2 MCF CNPs |
| M-CNPs (medium concentration) | BMSCs + 4 MCF CNPs |
| H-CNPs (high concentration) | BMSCs + 6 MCF CNPs |
| M-CNPs + SB431542 | BMSCs + 4 MCF CNPs, followed by 1-hour treatment with 10 μM SB431542 after 3 days of culture |
- Citation: Su XL, Xu FR, Yang J, Niu SQ, Shi HJ, He YF, Li ZH, Bagari P, Wu XW, Peng XY, Zhang HW, Wang MY. Calcifying nanoparticles induce apoptosis and calcification in bone marrow mesenchymal stem cells via the transforming growth factor-β/Smad pathway. World J Stem Cells 2025; 17(12): 106128
- URL: https://www.wjgnet.com/1948-0210/full/v17/i12/106128.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i12.106128